INT-767d (FXR/TGR5 agonist) in dogs: the evidence

What the aging-research databases and the canine literature hold for INT-767d (FXR/TGR5 agonist) (names searched: INT-767d (FXR/TGR5 agonist), INT 767d (FXR/TGR5 agonist), INT-767d-(FXR/TGR5-agonist), INT‐767d (FXR/TGR5 agonist)). Compiled from DrugAge, the canine aging corpus and FDA CVM FOI summaries; nothing here is inferred.

Lifespan experiments in other species (DrugAge)

2 experiments recorded, by species: Mus musculus 2.

NIA Interventions Testing Program rows

SpeciesStrainDoseAge at startDurationSexMean lifespan Δ%Mean sig.Max lifespan Δ%Max sig.Source
Mus musculusUM-HET3180 ppm food10 monthsuntil deathFemale-1NS0NSPMID 30688027
Mus musculusUM-HET3180 ppm food10 monthsuntil deathMale-3NS-4NSPMID 30688027

Lifespan experiments in dogs (DrugAge)

DrugAge records no dog lifespan experiment for this compound.

Dog-equivalent doses (allometric starting points, not recommendations)

Method: FDA 2005 Km body-surface-area conversion; starting-point heuristic only.

No mg/kg dose in DrugAge to translate (doses reported as ppm of diet or a concentration).

Canine aging literature (Europe PMC corpus)

0 corpus records mention this compound.

FDA CVM FOI summaries for dog products

No FDA FOI summary for a dog product contains this ingredient (it is not a marketed veterinary product).

Evidence gaps reported by the dossier tool

Reproduce: intervention_dossier(compound="INT-767d (FXR/TGR5 agonist)") in dog-geroscience-mcp.